Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences
Acumen Pharmaceuticals, a clinical-stage biopharmaceutical company focused on novel Alzheimer's therapeutics, will participate in upcoming investor conferences to discuss progress and developments. The company is advancing its lead drug candidate, sabirnetug, in Phase 2 trials and exploring innovative delivery technologies.